Authors
Nikolaos A Patsopoulos, Bayer Pharma MS Genetics Working Group, the Steering Committees of Studies Evaluating IFNβ‐1b and a CCR1‐Antagonist, ANZgene Consortium, GeneMSA, International Multiple Sclerosis Genetics Consortium, Paul IW de Bakker
Publication date
2011/12
Journal
Annals of neurology
Volume
70
Issue
6
Pages
897-912
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Description
Objective
To perform a 1‐stage meta‐analysis of genome‐wide association studies (GWAS) of multiple sclerosis (MS) susceptibility and to explore functional consequences of new susceptibility loci.
Methods
We synthesized 7 MS GWAS. Each data set was imputed using HapMap phase II, and a per single nucleotide polymorphism (SNP) meta‐analysis was performed across the 7 data sets. We explored RNA expression data using a quantitative trait analysis in peripheral blood mononuclear cells (PBMCs) of 228 subjects with demyelinating disease.
Results
We meta‐analyzed 2,529,394 unique SNPs in 5,545 cases and 12,153 controls. We identified 3 novel susceptibility alleles: rs170934T at 3p24.1 (odds ratio [OR], 1.17; p = 1.6 × 10−8) near EOMES, rs2150702G in the second intron of MLANA on chromosome 9p24.1 (OR, 1.16; p = 3.3 × 10−8), and rs6718520A in an intergenic region on chromosome 2p21 …
Total citations
2011201220132014201520162017201820192020202120222023202432744444845312424221518105